NDC 0093-5215

Moexipril Hydrochloride and Hydrochlorothiazide

Moexipril Hydrochloride And Hydrochlorothiazide

Moexipril Hydrochloride and Hydrochlorothiazide is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Moexipril Hydrochloride; Hydrochlorothiazide.

Product ID0093-5215_bde0e5f7-bb05-426b-970d-6e236651c0d8
NDC0093-5215
Product TypeHuman Prescription Drug
Proprietary NameMoexipril Hydrochloride and Hydrochlorothiazide
Generic NameMoexipril Hydrochloride And Hydrochlorothiazide
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2007-03-07
Marketing CategoryANDA / ANDA
Application NumberANDA076980
Labeler NameTeva Pharmaceuticals USA, Inc.
Substance NameMOEXIPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
Active Ingredient Strength15 mg/1; mg/1
Pharm ClassesAngiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0093-5215-01

100 TABLET, FILM COATED in 1 BOTTLE (0093-5215-01)
Marketing Start Date2007-03-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0093-5215-01 [00093521501]

Moexipril Hydrochloride and Hydrochlorothiazide TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA076980
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-03-07
Marketing End Date2019-11-30

Drug Details

Active Ingredients

IngredientStrength
MOEXIPRIL HYDROCHLORIDE15 mg/1

OpenFDA Data

SPL SET ID:621614de-4a5c-43c8-af77-e98128f01c8b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1299859
  • 1299890
  • 1299871
  • UPC Code
  • 0300935215013
  • 0300935213019
  • 0300935214016
  • Pharmacological Class

    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    NDC Crossover Matching brand name "Moexipril Hydrochloride and Hydrochlorothiazide" or generic name "Moexipril Hydrochloride And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    0093-5213Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    0093-5214Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    0093-5215Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    23155-035Moexipril hydrochloride and hydrochlorothiazideMoexipril hydrochloride and hydrochlorothiazide
    23155-036Moexipril hydrochloride and hydrochlorothiazideMoexipril hydrochloride and hydrochlorothiazide
    23155-037Moexipril hydrochloride and hydrochlorothiazideMoexipril hydrochloride and hydrochlorothiazide
    42291-576Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    42291-577Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    42291-578Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    68462-205Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    68462-206Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide
    68462-207Moexipril Hydrochloride and HydrochlorothiazideMoexipril Hydrochloride and Hydrochlorothiazide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.